NTLA Today - Jul 09: Mixed Signals in the Market

カートのアイテムが多すぎます

ご購入は五十タイトルがカートに入っている場合のみです。

カートに追加できませんでした。

しばらく経ってから再度お試しください。

ウィッシュリストに追加できませんでした。

しばらく経ってから再度お試しください。

ほしい物リストの削除に失敗しました。

しばらく経ってから再度お試しください。

ポッドキャストのフォローに失敗しました

ポッドキャストのフォロー解除に失敗しました

NTLA Today - Jul 09: Mixed Signals in the Market

無料で聴く

ポッドキャストの詳細を見る

Hey there! It’s Joey, your friendly neighborhood investor, and I’m breaking down what happened today with Intellia, or NTLA for short. So, today was a bit of a red day for them, down about 1% at $16.66. Yeah, that one stung a little.

Now, here’s the scoop. NTLA started off strong, even jumping in premarket trading thanks to some positive news about late-stage trial data for their gene-editing therapy. People were hyped, thinking it was a great moment to jump in. But as the day went on, the excitement fizzled out. The stock saw a good amount of volume but ended up just barely moving by the close. It seems like folks were a bit hesitant, hitting the sell button instead of piling on the buys.

So, why the sudden mood shift? Well, some articles pointed out that while Intellia is looking good in terms of potential sales, it’s not really delivering strong returns right now. Plus, there’s chatter that the stock might be around 37% below what it should be worth based on its gene-editing hopes. That could be making investors think twice. It’s like a classic case of “what have you done for me lately?” People are looking for those solid returns, and if they’re not seeing them, they might get skittish.

On the horizon, you should know that there’s been a lot of buzz about NTLA's upcoming earnings report. That could definitely shake things up, for better or worse.

So, in a nutshell, NTLA had a mixed day. They started strong but ended up feeling the heat from some cautious investors. As always, just keep in mind this is all for fun and info, not financial advice. Catch you later!

まだレビューはありません